Despite high demand for an option like Journavx, doctors fear the drug’s price could be a major hangup for insurers, potentially limiting patients’ ability to access it.

Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin. The U.S. Food ...

The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive ...

But experts say there may be a number of opportunities for lab-grown meat under a second Trump administration. Industry ...

In his first Senate confirmation hearing to be secretary of the Department of Health and Human Services, Robert F. Kennedy Jr ...

The FDA is overhauling food labels to redefine "'healthy," focusing on redefining terms and introducing new front-of-package ...

STATEN ISLAND, N.Y. — A December 2024 chocolate recall has been upgraded to highest risk level by the U.S. Food and Drug ...

Senators had objected to the financial conflict posed by Robert F. Kennedy Jr.’s decision to retain a financial stake in ...

The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals' drug to treat acute pain, the health regulator ...

The oversight could result in “death,” at least for those with a milk allergy or sensitivity, says the FDA. FDA initiated the ...

The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than two decades.

Robert F. Kennedy Jr. said he would hire a Native American to serve in his central office if confirmed as the nation's top health leader ...